Caricamento...
“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
The pharmaceutical industry faces unsustainable program failure despite significant increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets and increasing regulatory control, predict significant gaps in the future drug markets. The cumulative duration of discovery f...
Salvato in:
| Pubblicato in: | Proteomes |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217350/ https://ncbi.nlm.nih.gov/pubmed/28248238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/proteomes4030028 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|